argenx SE (EBR:ARGX)
665.60
-11.60 (-1.71%)
Apr 28, 2026, 5:35 PM CET
argenx SE Employees
argenx SE had 1,863 employees as of December 31, 2025. The number of employees increased by 264 or 16.51% compared to the previous year.
Employees
1,863
Change (1Y)
264
Growth (1Y)
16.51%
Revenue / Employee
€1,936,769
Profits / Employee
€590,674
Market Cap
42.11B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 9,765 |
| Onward Medical | 103 |
| Hyloris Pharmaceuticals | 50 |
| European Medical Solutions | 123 |
| Celyad Oncology | 5 |
| BioSenic | 7 |
| Oxurion NV | 11 |
argenx SE News
- 7 days ago - Noteworthy ETF Outflows: IBB, REGN, ARGX, INSM - Nasdaq
- 9 days ago - argenx (ARGX) Reveals New Vyvgart Data at 2026 AAN Annual Meeting - GuruFocus
- 10 days ago - argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP - GlobeNewsWire
- 11 days ago - Wedbush Reaffirms ARGX, NUVB, FENC At Outperform; Lifts PT For Kiniksa; Keeps NVCR At Neutral - Nasdaq
- 26 days ago - Oppenheimer Lowers Price Target for ARGX, Reiterates Outperform Rating | ARGX Stock News - GuruFocus
- 27 days ago - Goldman Sachs Highlights Argenx (ARGX) as Prime Growth Opportunity - GuruFocus
- 5 weeks ago - eClinical Solutions elluminate® Platform Supports argenx to Enhance Data Oversight and Efficiency - Business Wire
- 7 weeks ago - argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline - GlobeNewsWire